The head of  the Centre for State Control of Medicines, Equipment and Medical Devices (CECMED), says a clinical trial on a COVID-19 vaccination for children is currently underway and is progressing satisfactorily. 

According Dr Meiby de la Caridad Rodríguez González, the first anti-COVID-19 research in children and adolescents complied with a rigorous approval process seven weeks after the dossier was submitted to the regulatory authority and on June 14, during the application of the first dose, they had the first sanitary inspection by the CECMED.

The Soberana-Paediatrics clinical trial, includes in its first and second phase, children and adolescents between three and 18 years of age, healthy, of Cuban nationality.

Fifty volunteers have been included in the first stage and 300 in the second.

The health authorities said the study will be carried out sequentially, after the first week of immunisation, blood tests will be performed to determine the safety of the product, to request the approval of CECMED with a view to continue with the group from three to 11 years of age and to continue towards phase II with a greater number of adolescents.

The first stage of the research will be carried out at the Juan Manuel Márquez Paediatric Hospital and later the trial will be extended to the health areas of the municipalities of Playa, Marianao and La Lisa, said Rodríguez González.

Follow The Gleaner on Twitter and Instagram @JamaicaGleaner and on Facebook @GleanerJamaica. Send us a message on WhatsApp at 1-876-499-0169 or email us at onlinefeedback@gleanerjm.com [2] or editors@gleanerjm.com [3].